Perioperative Recombinant Human Granulocyte Colony-Stimulating Factor (Filgrastim) Treatment Prevents Immunoinflammatory Dysfunction Associated With Major Surgery
Authors:
- 1 January 2004
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 239 (1) , 75-81
Abstract
To examine the effects of perioperative rhG-CSF administration on immune function in patients subjected to major surgery. Severe trauma, such as major surgery, initiates acute immunodysfunction which predisposes the patient towards infectious complications. Sixty patients undergoing elective surgery received either recombinant human granulocyte colony-stimulating factor/rh G-CSF (Filgrastim) or a placebo perioperatively. At several time points before and after the surgical intervention immunofunctional parameters were assessed. Leukocyte counts and serum levels of anti-inflammatory mediators (IL-1ra and TNF-R) were increased in Filgrastim-treated patients, while the post-operative acute phase response was attenuated. Monocyte deactivation (reduced TNF-α release and HLA-DR expression) and lymphocyte anergy (impaired mitogenic proliferation and reduced TH1 lymphokine release) were blunted and the incidence and severity of infectious complications were reduced. These results suggest that Filgrastim treatment reinforces innate immunity, enabling better prevention of infection. Thus, this unique combination of hematopoietic, anti-inflammatory and anti-infectious effects on the innate immune system warrants further study of clinical efficacy and sepsis prophylaxis.Keywords
This publication has 42 references indexed in Scilit:
- Interferon-?? Modifies Cytokine Release In Vitro by Monocytes from Surgical PatientsThe Journal of Trauma: Injury, Infection, and Critical Care, 2001
- Control of Fecal Peritoneal Infection in Mice by Colony-Stimulating FactorsThe Journal of Infectious Diseases, 1996
- Changes in Granulocyte Colony-Stimulating Factor Concentration in Patients with Trauma and SepsisThe Journal of Trauma: Injury, Infection, and Critical Care, 1996
- Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemiaClinical and Experimental Immunology, 1995
- THE USE OF GRANULOCYTE COLONY-STIMULATING FACTOR AFTER LIVER TRANSPLANTATIONTransplantation, 1995
- INADEQUATE INTERLEUKIN-2 SYNTHESIS AND INTERLEUKIN-2 MESSENGER EXPRESSION FOLLOWING THERMAL AND MECHANICAL TRAUMA IN HUMANS IS CAUSED BY DEFECTIVE TRANSMEMBRANE SIGNALLING1993
- Effect of Granulocyte Colony-Stimulating Factor on Sepsis-Induced Changes in Neutrophil Accumulation and Organ Glucose UptakeThe Journal of Infectious Diseases, 1992
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992
- Trauma and the immune responseImmunology Today, 1988